{"name":"I-Mab Biopharma HongKong Limited","slug":"i-mab-biopharma-hongkong-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPQ0IyRmpWZzhoSnhlMVFEdVdtRzM2TjRtN0FfSXp5YjBSMHJVcGZwNlJxR09OODhWQWhIM3NRcV9pdEczQUhiaEs1aXpXYVlRWFlWb1k5QVVfd0t5bmQxRmVGblpDZVM4SmRtN2taaExmRU9KN3BmLU95bVRRM1V4aWtYaEZQVGpZNzRsOEVrSTdVc2FiVTFDcDJhb19DczA5M2IzM0FR?oc=5","date":"2025-12-09","type":"pipeline","source":"BioWorld News","summary":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025 - BioWorld News","headline":"73 Chinese biotech, med-tech companies file for HK IPOs in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQQUlaRUJ3MG0zRGJfR2IwRkYyOVYtM3VOOV84bk1OaG5DNGNKbzZIcjBPeVI3cGJEXzBFd1o4dXJ5YTlKWS1sSTlBTDdLRUxNLWJyMXh1SG1UV2JtZlFlODh2WU1uZEZEbC1Ia0hHZlUzZEF5TFZOckNUQVUtSWFNaHBfbXgyOWxNQUFIXzdaQWtzUUlleGR6cllhdXlWYWo2eEtlcGNWZ2NUaS1UWmpF?oc=5","date":"2025-10-17","type":"pipeline","source":"Fierce Biotech","summary":"I-Mab undergoes makeover, with new name, strategy, asset and Hong Kong IPO plans - Fierce Biotech","headline":"I-Mab undergoes makeover, with new name, strategy, asset and Hong Kong IPO plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxPZmRFVkszUElfVjBEeUItdWpKb0lLdk9FdF9RSU56NEJVM2JZaURvTjFNZGFnanhEVG05b3dweWE4T29pcVBjQ1AxZDB6MFFRZThTLWpPdENBbmtuM2dVZ25rSFJtc1F5Yk82aXRhTnB1LW15TFFuRkh6QWVXVFI1SUd2WFJBa3dyQ3F6UUhVdS1seWMyUWxYMXJuS053bnVLWDZpQ1phS0ZLS0l6TFZuaGp2eS1pa29qOUpnMXIwcTVxeEFrTjlVY0hGTVB4ckRZZjJLaTFnNFk1N29JQnQ5dGhIUXJ5Y21fM3JmMzZ3Z2lNWjF6Wk9DX2xHdTUxYjhUUXkydHo4cDRBd29fT2M5UWZ2YkxmeklrY0hiS3Q3Mk1jTGtWYkFUVVBOMU1BaXdZa2g0aDFlR2UyUkplY05OSWRKVVh5aTg?oc=5","date":"2025-10-16","type":"pipeline","source":"GlobeNewswire","summary":"I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences - GlobeNewswire","headline":"I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQX1l6UzZuUVk4UnVwWHVLRVJaTHh6eFRnZGhMd2s0ZlRNWHV6QmxfMXo1aGUyNUtqNHV6bGFQelFvdHltUUVEaGtPUDBzVjIwQ1RxZVNvYUpZMjJfV3F0OUZmMXpBSzNuUG1Ta0VmX3JjYlBLM0pGRmRfM3hyN0puZVVSNV82NmlKTW5ZR0QtQXQ4NW9zdHVsWDM3MkpJcVVkcUlBaXp1QUxidGpwWDlKU3pnZXVHaGhFbTEtWms4bUNFNWpZRUxIR0VzUldJMmx1eHFaT2ZSbnhxSlhEN2ZCUmRfSEwtWUprOENMNjZTZ2VGTmpWRmJXWVRUUUM?oc=5","date":"2025-09-02","type":"pipeline","source":"GlobeNewswire","summary":"Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million - GlobeNewswire","headline":"Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQRmdITkIzU1l0cTZ1VjZreGFMS19VLUxPOFdLLW9xeWdxMkIzaEg3VnJJSEk3SzBsSFNibUxSWTlpM1ZRcWthNllUT1d0OVBnd1lUUG85RkdUOWlrQWJIMHNyVElvVi1MUlNmczJNNUpZSV9QSlNQS3BCREVhYS1LS01nRUhESk9Ic0lLOGdkOHN2QjRHZlRESVdnbTdjbHdlTURz?oc=5","date":"2025-07-24","type":"pipeline","source":"BioWorld News","summary":"34 mainland China biotechs file for Hong Kong IPO in H1 2025 - BioWorld News","headline":"34 mainland China biotechs file for Hong Kong IPO in H1 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBUYV9rNlpWLVVMc0JnMEVwMFJuSlN5bEExU3Z5ZGJXcDVQUjM3cjFaWDByYlBfdW5yNV9Na20xa1E0N2NRSVRFa3YzdlJ5bGd2SENvd3BqazFPcHlqa1RoRGh1T1J4c1h1SE5tbkM4czFlbTRVdVRJ?oc=5","date":"2025-03-28","type":"pipeline","source":"Yicai Global","summary":"Weisheng Pharmaceutical, which has suffered continuous losses in performance, broke in the IPO of Hong Kong stocks - Yicai Global","headline":"Weisheng Pharmaceutical, which has suffered continuous losses in performance, broke in the IPO of Hong Kong stocks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxPeXRiZXpKQ295c3N6M3c3RG9mVWI3U2JOZ0FtQ28zQVBKZVRTRnRhaGxBMkQtZXNSRmhsNGV2Ty1OQXJnX3VMSjlxNkh1X0xOQkdNSS1WTWRFTm82eS1TQjVvUnAwQTlFQ2RmYlM2bm92bHMta3NNV2gxSmV6TkFKOVpYZUw5SU1VajUwZlRKc01Pa1ZCQXo4M05JOVc2LTlKWG5yTEZMbGxwZHVlRTFCcFNQQzMxNGY4T2dzc0Z3RXFWMHhQTTJ2S0thLWI3WWs?oc=5","date":"2024-08-28","type":"pipeline","source":"PR Newswire","summary":"I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates - PR Newswire","headline":"I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business Updates","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxORjN0WVR2SU9KcnRvbW43dFJkc24wUlBNM0xYdGVJVE9KdHV4eUpMYlBqd3BGamRPYTR3bWlPMXBRRDVaMTNWTXMyajBQSTFhSE5IaUZreEpFc25FQjVEbkJzNmVBUENpMkdfcFlLaElHdkZ5MGxDaEZsVHExV1BwRDFDTzNScU4xdndjRF9JaEE2emhCLTIzcGlIUDJRcjAtTTQ2TDk3cGRXWFpYWms5OWx4SUFVa3REY3ZpekFyQkxJbXFPMFkzcVI0UQ?oc=5","date":"2024-02-07","type":"pipeline","source":"PR Newswire","summary":"I-Mab Signs Agreement to Divest its Assets and Business Operations in China - PR Newswire","headline":"I-Mab Signs Agreement to Divest its Assets and Business Operations in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE0yeWxPcGR0dHhDcDJJNlhBZmRFMXFsaGhvTmJjUGMtSG5tS0l1dzl2MFNkZW5SZnBLekFvQUhaczhWNmF5Ymk5SGRHWUMzWktOWlh6a3dpUGlNSndYd3dKVw?oc=5","date":"2023-10-27","type":"deal","source":"复宏汉霖","summary":"Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India - 复宏汉霖","headline":"Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India - 复宏汉霖","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPWHRKZFFDTllfMXcxRXlYeXJRLURtX0ZSemkyeVBJU09NODZlN0YyODVxaFoteFFwSHE4NU5RSG9ZRnI1Q3VQb1hpbjN1ZFdyM3B0dTJpdGFLRjhfS2N2bmxaVXpZZ1p1VWFkNkFNTEVEMEtONVdXamwtYmhrY0VtcFUzZnRCTU00a1AwaWRzdFRiY0Fwel9Tc2dfVlluRkdRbEhLb0lsUFhCN3h5UmR5Z3Bscm5HWkFLQnJJNmVkRjZCVzhnV0JNX3Q3T2EwYVJTQS1N?oc=5","date":"2021-10-26","type":"deal","source":"BioSpace","summary":"I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China - BioSpace","headline":"I-Mab Announces Strategic Partnership with Sinopharm in Preparation for Launch of its Innovative Assets in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE4wc0ZmeW9fdUVSNDVoQVdzTjVxWHRfMzcyUWdwaGZ0LVhNTVUwQWo3bE1uZ29lcmFzZ3RzYklDX0NTZ2RXb0JFQmVKc3hlZDVLWC15VEFxOFd3Ni1GY2dMV3FR?oc=5","date":"2021-08-21","type":"pipeline","source":"康方生物","summary":"Akeso Shipped off its First Batch of Penpulimab Monoclonal Antibody Injection (安尼可®) - 康方生物","headline":"Akeso Shipped off its First Batch of Penpulimab Monoclonal Antibody Injection (安尼可®) - 康方生物","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1Mb0REVGt6WWJCTlRfRG5PNTZrSUZJVTZIU1NWOXdkSzNkend0elpjcVdkUGo1UmdLQTMyM2RzZ2dXOUUyRDNlUkNDZklWa1hlWXVWZmNLSUlva2xvdTFzckVNMmRmbllPOVJ1TlNaQWVmSW9zNlJNZQ?oc=5","date":"2020-11-10","type":"pipeline","source":"Fierce Pharma","summary":"10 biotechs to know in China - Fierce Pharma","headline":"10 biotechs to know in China","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}